News & Insights

Brent Saunders: Eyeing New Horizons
Pharmaceutical Executive highlights Bausch + Lomb’s transformation under Brent, with a focus on the company’s rebuilt pipeline.

Q&A: Brent Saunders on pushing Bausch out of neutral, scrutinizing new hires and why TrumpRx matters
Brent speaks with Senior Biopharma Correspondent Andrew Dunn for an Endpoints News feature.

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical
Brent joins CNBC’s “Squawk Box” live in studio.

Bausch + Lomb CEO Brent Saunders on Comeback, R&D Innovation, and Eye Care’s Evolution
Brent joins the New York Stock Exchange’s “Inside the ICE House” podcast for a wide-ranging interview in advance of Bausch + Lomb Investor Day.

“CHABÁN Podcast” interview
Brent joins Alejandro Chabán for a discussion on reinvention, growth and leadership.

“Opening Bid” podcast interview
Brent joins Brian Sozzi on the Yahoo Finance “Opening Bid” podcast for a wide-ranging conversation.

Brent Saunders: Eyeing New Horizons
Pharmaceutical Executive highlights Bausch + Lomb’s transformation under Brent, with a focus on the company’s rebuilt pipeline.

Q&A: Brent Saunders on pushing Bausch out of neutral, scrutinizing new hires and why TrumpRx matters
Brent speaks with Senior Biopharma Correspondent Andrew Dunn for an Endpoints News feature.

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical
Brent joins CNBC’s “Squawk Box” live in studio.

Bausch + Lomb CEO Brent Saunders on Comeback, R&D Innovation, and Eye Care’s Evolution
Brent joins the New York Stock Exchange’s “Inside the ICE House” podcast for a wide-ranging interview in advance of Bausch + Lomb Investor Day.